Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02923583 | Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects | PHASE1 | COMPLETED | 243 | — | — | Oct 1, 2016 | Jul 1, 2017 | Oct 23, 2017 | - | — |
| Name | Type | Description |
|---|---|---|
| M834 | BIOLOGICAL | - |
| US-Sourced Orencia® | BIOLOGICAL | - |
| EU-Sourced Orencia® | BIOLOGICAL | - |